RecruitingPhase 4NCT06213324

Neural Circuit Effects of Ketamine in Depression

Studying Familial LCAT deficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Icahn School of Medicine at Mount Sinai
Principal Investigator
James Murrough, MD/PhD
Icahn School of Medicine at Mount Sinai
Intervention
Ketamine(drug)
Enrollment
120 target
Eligibility
18-65 years · All sexes
Timeline
20242028

Study locations (1)

Collaborators

National Institute of Mental Health (NIMH)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06213324 on ClinicalTrials.gov

Other trials for Familial LCAT deficiency

Additional recruiting or active studies for the same condition.

See all trials for Familial LCAT deficiency

← Back to all trials